Efficacy and safety of Losigamone in partial seizures: A randomized double-blind study

Epilepsy Research

Volumn 55, Issue 3, 2003, Pages 177-189

  Baulac, M ^a   Klement, S ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Anticonvulsants; Antiepileptic drug; Double blind study; Losigamone; Partial epilepsy; Seizures

Indexed keywords

LOSIGAMONE; PLACEBO;

ABDOMINAL PAIN; AGGRESSION; ANOREXIA; ARTICLE; ATAXIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; DEPRESSION; DIARRHEA; DIPLOPIA; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FOCAL EPILEPSY; GAIT DISORDER; HEADACHE; HUMAN; MALE; MORBIDITY; NAUSEA; PAIN; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; SOMNOLENCE; TREMOR; VERTIGO; VISUAL DISORDER; VOMITING;

EID: 0042827363     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(03)00108-6     Document Type: Article

References (19)

1. Bauer, J., Dienel, A., Elger, C.E., Losigamone Study Group, 2001. Losigamone add-on therapy in partial epilepsy: a placebo-controlled study. Acta Neurol. Scand. 103, 226-230.
2. Chatterjee S.S., Nöldner M. Losigamone: from plant extract to antiepileptic drug. CNS Drug Rev. 3:1993;1-20.
3. Cramer J.A., Fisher R., Ben Menachem E., French J., Mattson R.H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia. 40:1999;590-600.
4. A receptor system. Epilepsia. 36:1995;983-989.
5. Köhr G., Heinemann U. Anticonvulsant effects of tetronic acid derivatives on picrotoxin induced epileptiform activity in rat hippocampal slices. Neurosci. Lett. 12:1990a;43-47.
6. Köhr G., Heinemann U. Effects of tetronic acid derivatives AO-33 (Losigamone) and AO-78 on epileptiform activity and on stimulus induced calcium concentration changes in rat hippocampal slices. Epilepsy Res. 7:1990b;49-58.
7. Krämer G., Wad N., Bredel-Geissler A., Dienel A., Biber A. Losigamone interactions with antiepileptic drugs in healthy volunteers. Epilepsia. 37(Suppl. 4):1996;89.
8. 2+ concentration in rat hippocampal slices. Exp. Brain Res. 96:1993;230-240.
9. Maurer, W., Hothorn, L., Lehmacher, W., 1995. Multiple comparisons in drug clinical trials and pre-clinical assays: a priori ordered hypotheses. In: Vollmar, J. (Ed.), Testprinzipien in Klinischen und Präklinischen Studien, vol. 6. Gustav-Fischer Verlag, Stuttgart, Jena, New York, pp. 3-18.
10. Morris G.L., Collins S., Bell W., Sahlroot J.T., Matula M., Cereghino J.J. Losigamone: putative antiepileptic drug. J. Epilepsy. 10:1997;62-66.
11. Nöldner M., Chatterjee S.S. Losigamone. Drugs Future. 15:1990;995-996.
12. Schmitz D., Gloveli T., Heinemann U. Effects of losigamone on synaptic potentials and spike frequency habituation in rat entorhinal cortex and hippocampal CA1 neurons. Neurosci. Lett. 200:1995;141-143.
13. Semah F., Picot M.C., Adam C., Broglin D., Arzimanoglou A., Bazin B., Cavalcanti D., Baulac M. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 51:1998;1256-1262.
14. Stein, U., 1995. Potential antiepileptic drugs: Losigamone. In: Levy, R.H., Mattson, R.H., Meldium, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 1025-1034.
15. Stein, U., Klessing, K., Chatteriee, S.S., 1991. Losigamone. In: Pisani, F., Perucca, E., Avanzini, G., Richens, A. (Eds.), New Antiepileptic Drugs. Epilepsy Res. Suppl. 3, 129-133.
16. Swinyard, E.A., Wolf, H.H., Franklin, M.R., White, H.S., Woodhead, J.H., Kupferberg, H.J., Stables, J.P., 1988. The Profile of Anticonvulsant Activity and Acute Toxicity of 137021, 137022, and Some Prototype Antiepileptic Drugs in Mice and Rats. The Early Evaluation of Anticonvulsant Drugs. Red Book, 12/5/88.
17. Srinivasan J., Richens A., Davies J. The effect of losigamone (AO-33) on electrical activity and excitatory amino acid release in mouse cortical slices. Br. J. Pharmacol. 122:1997;1490-1494.
18. Yonekawa W.D., Kapetanovic J.M., Kupferberg J.H. The effects of anticonvulsant agents on 4-aminopyridine-induced epileptoform activity in rat hippocampus in vitro. Epilepsy Res. 20:1995;137-150.
19. Zhang C.L., Chatterjee S.S., Stein U., Heinemann U. Comparison of the effect of losigamone and its isomers on maximal electroshock induced epileptiform activity in slices of the rat temporal cortex. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;85-92.